Molecular Profiling–Based Precision Medicine in Cancer: A Review of Current Evidence and Challenges
Author:
Funder
National Natural Science Foundation of China
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference65 articles.
1. Crizotinib in ROS1-rearranged non-small-cell lung cancer;Shaw;N Engl J Med,2014
2. Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component;Yang;J Clin Oncol,2017
3. 11 years’ follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial;Cameron;Lancet,2017
4. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011
5. Discovery and saturation analysis of cancer genes across 21 tumour types;Lawrence;Nature,2014
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of Needles in Endoscopic Ultrasound-Guided Tissue Acquisition of Pancreatic Cancer for Genetic Yield and Quality;Cureus;2024-09-02
2. Personalized Medicine in Pancreatic Cancer: The Promise of Biomarkers and Molecular Targeting with Dr. Michael J. Pishvaian;Cancers;2024-06-26
3. Hallmarks of cancer resistance;iScience;2024-06
4. Comprehensive molecular profiling identifies actionable biomarkers for patients from Thailand and the United Arab Emirates with advanced malignancies;Frontiers in Oncology;2024-05-10
5. Prognosis value of heat-shock proteins in esophageal and esophagogastric cancer: A systematic review and meta-analysis;World Journal of Gastrointestinal Oncology;2024-04-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3